In a recent revelation, Tesla’s trailblazing founder, Elon Musk, opened up about his struggle with depression. Musk’s candid admission has shed light on the mental health challenges faced by successful entrepreneurs.
Musk shared that his prescribed medication, ketamine, has proven beneficial not only for his well-being but also for Tesla’s stakeholders. He emphasized that the prosperity of Tesla, which rivals the combined worth of the global auto industry, is intrinsically linked to his mental health. Consequently, any therapeutic measures he undertakes indirectly serve the interests of the investors.
In an act of transparency, Musk publicly discussed his use of ketamine, advocating its potential benefits for those grappling with depression. He suggested that ketamine might offer superior efficacy compared to commonly used Selective Serotonin Reuptake Inhibitors (SSRIs).
Musk’s frank discussion about his mental health journey and the use of ketamine was met with support from the interview host, Jim Cramer. This conversation underscores the importance of mental health awareness and the need for open dialogues about depression, even among high-profile individuals.
